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Autism spectrum disorders (ASDs) are characterized by impaired communication, social
impairments, and restricted and repetitive behaviors and interests. Recently, altered moti-
vation and reward processes have been suggested to participate in the physiopathology of
ASDs, and µ-opioid receptors (MORs) have been investigated in relation to social reward
due to their involvement in the neural circuitry of reward. Mice lacking a functional MOR
gene (Oprm1−/− mice) display abnormal social behavior and major autistic-like core symp-
toms, making them an animal model of autism.The oxytocin (OXT) system is a key regulator
of social behavior and co-operates with the opioidergic system in the modulation of social
behavior. To better understand the opioid-OXT interplay in the central nervous system,
we first determined the expression of the oxytocin receptor (OXTR) in the brain of WT
C57BL6/J mice by quantitative autoradiography; we then evaluated OXTR regional alter-
ations in Oprm1−/−mice. Moreover, we tested these mice in a paradigm of social behavior,
the male–female social interaction test, and analyzed the effects of acute intranasal OXT
treatment on their performance. In autoradiography, Oprm1−/− mice selectively displayed
increased OXTR expression in the Medial Anterior Olfactory Nucleus, the Central and
Medial Amygdaloid nuclei, and the Nucleus Accumbens. Our behavioral results confirmed
that Oprm1−/− male mice displayed social impairments, as indicated by reduced ultra-
sonic calls, and that these were rescued by a single intranasal administration of OXT.Taken
together, our results provide evidence of an interaction between OXT and opioids in socially
relevant brain areas and in the modulation of social behavior. Moreover, they suggest that
the oxytocinergic system may act as a compensative mechanism to bypass and/or restore
alterations in circuits linked to impaired social behavior.
Keywords: oxytocin receptor, µ-opioid receptor, brain autoradiography, social behavior, autism, Oprm1−/− mice,
ultrasonic vocalizations
INTRODUCTION
Autism spectrum disorders (ASDs) are characterized by a triad of
symptoms that includes impaired communication, social impair-
ments, and restricted and repetitive behaviors and interests (1).
The prevailing hypothesis regarding the physiopathology of ASDs
identifies the area of social cognition as a primary deficit. In par-
ticular, it focuses on the impaired capabilities of affected people to
attribute mental states to others (and oneself) in order to explain
and predict behavior (i.e., the theory of mind hypothesis proposed
by Baron-Cohen and colleagues (2, 3). However, altered affectiv-
ity is evident in autistic children (4) and, as recently proposed by
Chevallier and others (5), motivation and reward processes might
also participate to the physiopathology of ASDs. Reward circuitry
dysfunctions might lead to deficits in social seeking and mainte-
nance, resulting in reduced social capabilities and interests, and if
appearing early in life, in social learning. Deficit in social cognition
will thus be a consequence, rather than a cause, of impaired social
behavior. Excessive brain opiate activity has been proposed in the
past as a neurochemical feature in autism (6) and due to their
involvement in the neural circuitry of reward, µ-opioid receptors
(MORs) have also been investigated in relation to social reward,
emotion, and social behavior (7–9), and represent a key target to
understand the neurobiological basis of social reward dysfunction
in humans and animals.
In humans, MOR activation in specific brain regions such as the
amygdala, the periaqueductal gray, and the subgenual cingulated
cortex is believed to be protective or adaptive in relation to social
rejection. In fact, positron emission tomography (PET) scanning
showed that social rejection, exemplified by a paradigm in which
the test subject shows interest toward another individual who does
not return it, could increase the binding of endogenous opioids to
MOR in these areas, where greater binding also seemed to correlate
to better resiliency. In a contest of social acceptance, MOR acti-
vation in the ventral striatum was shown to correlate with desire
for social interaction (10). In a similar study, the G variant of
the A118G polymorphism of the MOR-encoding gene (OPRM1)
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correlated with a greater sensitivity to social rejection, reflected
in a higher activation of specific brain regions, such as the dorsal
anterior cingulate cortex and the anterior insula. Genetic varia-
tions in the OPRM1 gene can also influence individuals’ ability to
engage in social interactions. People carrying the G allele of the
A118G polymorphism of the OPRM1 gene seem to experience a
greater pleasure during social situations and they tend to engage in
affectionate relationships more easily in comparison with people
carrying the more common A variant of the gene (11). A crucial
role of MOR in partner preference has also been established by
studies in prairie and mountain voles. In the monogamous prairie
vole, dorsal striatal MOR has been proved fundamental for the
development of partner preference, which leads to the establish-
ment of pair bonding, although pharmacological disruption of
MOR signaling did not consistently alter the pattern of mating
behaviors (9, 12).
In species where individuals develop selective affective bonds
during their life, such as sheep or primates, MOR signaling has
been implicated in the modulation of the mother–infant attach-
ment: in infant rhesus macaques the genetic variant C77G of the
MOR gene, which increases its affinity for β-endorphin (13), has
been associated with increased attachment to the mother and
stronger protest response and distress during separation (14). At
the same time, the maternal attachment toward the offspring seems
to be subjected to MOR effects. Higham and colleagues (15) evi-
denced that free-ranging macaque females carrying at least one
copy of the minor allele (G) of the OPRM1 gene were more pos-
sessive toward their infants than mothers homozygous for the C
allele. Mouse pups where the MOR gene (Oprm1) has been per-
manently disrupted (Oprm1−/− mice) produce fewer ultrasound
vocalizations (USVs) in response to isolation from the mother
when compared to wild type mice, to indicate that lack of MOR
may induce resilience to isolation (16). Moreover, it is possible
that the lack of MOR prevents the establishment of an association
between maternal stimuli and feelings of reward, as transgenic
mice do not show a marked preference for a familiar environment
over an unfamiliar one (16). Later on in their life, these mice display
reduced interest for interaction with other mice of the same sex
and age (17) and they appear indifferent to ultrasounds emitted by
mice of the opposite sex (18). A recent extensive behavioral charac-
terization of Oprm1−/−mice confirmed that these animals display
major autistic-like core symptoms and elegantly provided key neu-
roanatomical and neurofunctional correlates (19). In particular,
Oprm1−/− mice display abnormal social behavior, as evidenced
by a decreased time in close social contact and increased self-
grooming in the direct social interaction test, reduced sociability,
and social novelty recognition in the three chamber test, accom-
panied by increased aggression, and impaired ability in building a
nest. These mice also display increased perseverative and stereo-
typed behaviors such as increased rearing, grooming, circling, and
head shaking associated with behavioral inflexibility, as evidenced
by deficient pattern of exploration in a Y-maze test. Concerning
the neurobiological substrates of such phenotype, of particular
interest is the observation of changes in oxytocin (OXT) gene
expression in specific areas of the brain: OXT transcripts were
found to be reduced in the Nucleus accumbens (NAcc) but not in
the Caudate–putamen (CPu) and Central amygdala (CeA) (19).
Together with the opioid system, the OXT system is a key regu-
lator of all the aspects of social behavior, including those involved
in reproduction and care of the offspring (20). In humans, OXT
facilitates the processing of social information, improves cognitive
emphatic abilities and increases interpersonal trust (21). As orig-
inally put forward by Modahl (22), a deficit in the OXT system
linked to an altered opioid regulation may underline the social
deficits in autism. Evidence of opioid–OXT interactions is indeed
well established. Endogenous opioids are involved in the modu-
lation of OXT release into the brain and the periphery via mu-
and kappa-receptors expressed on OXT-secreting neurons (23–
26). Even though the opioidergic modulation of OXT release may
account for many shared effects, the interplay of these two systems
does not probably end with that. A social motivation circuitry in
which OXT, vasopressin, endogenous opioids, and catecholamines
were hypothesized to participate in a wide variety of affiliative
behaviors was proposed more than 15 years ago (27) and has been
more recently integrated into a network of neurobiological mech-
anisms, which include neuronal, neurotransmitters, and hormone
systems whose alterations could underline the social impairment
observed in autism (28).
To contribute to unravel the critical interactions between the
opioid and OXT systems in the brain, we first reviewed the lit-
erature on oxytocin receptor (OXTR) and MOR distributions in
the mouse brain. As shown in Table 1, we found an overlapped
receptors’ expression in several regions involved in social behavior.
This observation suggests that OXTR and MOR may recip-
rocally modulate each other even at the cellular and/or molecu-
lar level. To investigate, if alterations in MOR expression might
induce changes in the OXTergic system we decided to evalu-
ate the expression and distribution of OXTRs in the brain of
Oprm1−/− mice.
Oxytocin receptors represent the pharmacological target of
OXT, and OXT administration has been proposed as a potential
treatment of social deficits in autistic patients (35). In particular,
intranasal OXT administration is believed to circumvent the poor
blood–brain barrier (BBB) permeability of this peptide. Even if the
direct passage of intranasal OXT into the brain is still matter of
debate (36, 37) acute and chronic intranasal OXT administration
have been shown to exert behavioral effects in rodents (34, 38, 39).
Even if it cannot be excluded that some of the behavioral effects
of OXT are mediated via peripheral mechanisms, intranasal OXT
administration in awake animals represents at present the most
convenient and reproducible method to assess the therapeutic
effects of this peptide on social behavior. We thus tested Oprm1−/−
mice in a paradigm of social behavior and analyzed the effect of
intranasal OXT treatment on their behavioral performances.
MATERIALS AND METHODS
ANIMALS AND HOUSING CONDITIONS
Oprm1+/+ (WT) and Oprm1−/− mice were used in this study.
Oprm1−/− mice were generated by disruption of exon 2 in the
Oprm1 gene as described elsewhere (40). The homozygotic par-
ents (Oprm1+/+ and Oprm1−/−) were derived from heterozy-
gous breeding pairs that were fully backcrossed on a C57BL6/J
genetic background. The two homozygous lines were maintained
separately. Animals were weaned when 28-day-old and maintained
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Table 1 | MOR and OXTR expression levels in mouse brain as reported in the literature.
Brain region MOR Reference OXTR Reference
Olfactory bulb + (29–31) +++ (32)
Anterior olfactory nucleus ++ (31) +++ (32–34)
Lateral Septum +/++ (29–31) +++ (32, 34)
Bed nucleus of the stria terminalis ++ (29–31) +/+++ (32)
Amygdala
Basolateral (comprising BLA and BLP) ++/+ (29–31) ++ (33)
Medial ++++ (29–31) ++ (32)
Central ++++ (31) ++/+++ (32, 33)
Cortical amygdaloid area ++ (31) +++/++++ (32, 33)
Amygdalohippocampal area + (31) ++/+++ (33)
Hippocampus + (29–31) ++ (32–34)
Caudate–putamen ++/+++ (29–31) + (32)
Nucleus accumbens ++++/++ (29–31) +/++++ (32–34)
Paraventricular thalamic nucleus +++ (31) ++ (32, 33)
Habenula ++++ (29–31) N.D.
in same sex/genotype groups of four to five subjects in transpar-
ent high-temperature polysulfone cages (27 cm× 21 cm× 14 cm)
with water and food available ad libitum (2018 Teklad Global 18%
Protein Rodent Diet, Harlan, Lyon, France). Room temperature
(21± 1°C) and a 12:12 h light–dark cycle (lights on at 1900 h)
were kept constant.
Two different groups of adult WT and Oprm1−/−male mice (3–
4 months old) were used: the first group (4 WT and 3 Oprm1−/−
mice, one subject per litter) was used for autoradiography and his-
tological examination; the second group of males (18 WT from 6
litters and 17 Oprm1−/−mice from 7 litters) underwent intranasal
OXT treatment; USVs and behavior during exposure to a female
partner were observed shortly after. The genotype of all ani-
mals used in this study was controlled by PCR at the end of the
experiment, according to already described procedures (40). Every
animal procedure used was in strict accordance with standard eth-
ical guidelines (European Community Guidelines on the Care and
Use of Laboratory Animals 2010/63/EU) and the Italian legislation
on animal experimentation (D.Lvo 116/92).
OXTR AUTORADIOGRAPHY
Naïve WT and Oprm1−/− mice were sacrificed by cervical dis-
location, the brains quickly removed and immediately frozen by
immersion in cold isopentane at −25°C and subsequent storage
at−80° C.
Coronal brain sections (14µm) were sliced with a cryostat,
thaw-mounted on microscope slides pre-coated with chrome-
alum–gelatin and kept at−80°C until further use.
Oxytocin receptor autoradiography was performed as
described in Huang et al. (34). Briefly, sections were fixed with
0.2% paraformaldehyde in 0.1 M phosphate-buffered saline (pH
7.4) and rinsed twice with 0.1% bovine serum albumin in 50 mM
Tris-HCl buffer (pH 7.4). OXT binding sites were detected by
incubation (1 h at room temperature in a humid chamber) with
the radioiodinated OXTR antagonist ornithine vasotocin analog
([125I]-OVTA, specific activity 2200 Ci/mmol; Perkin Elmer, MA,
USA) at 0.02 nM in a medium containing 50 mM Tris-HCl,
0.025% bacitracin, 5 mM MgCl2, and 0.1% bovine serum albumin.
Sections immediately adjacent to the ones used for [125I]-OVTA
binding were used to determine non-specific binding by addition
of 2µM OXT to the incubation solution.
At the end of binding, the unbound excess of ligand was
washed out by two rinses in ice-cold incubation medium and a
final rinse in cold distilled water. The slides were quickly dried
under a stream of cool air and exposed to Biomax MR Films
(Kodak) in an autoradiographic cassette for 72 h. The final autora-
diograms were digitalized by grayscale high-resolution scanning
(600× 600 dpi) and analysis of the optical binding density of the
brain regions of interest (ROIs) was carried out using the ImageJ
1.47v software (NIH, USA). ROIs were identified by comparison
with a reference mouse brain atlas (41) and manually delineated
with the ROI manager tool of the software. Specific densitometric
gray intensity was calculated by subtraction of the gray level of
the respective section treated for non-specific binding. For each
animal, the final gray intensities of each brain region were cal-
culated by averaging two [for anterior olfactory nucleus (AON),
LS, AHiPM, BLP, and PMCo] or three (for OB, NAcc, CPu, Hipp
CA3, PV, Hb, BLA, MeA, and CeA) sections at different coro-
nal planes from bregma. The regions of a limited rostro-caudal
extension [medial AON (AONm) and BNST] were analyzed on
a single coronal plane from bregma. Brain regions were selected
on the basis of co-expression of OXTR and MOR receptors at
medium-high level as resulting from a review of the data cur-
rently available in the literature and summarized in Table 1. Even
though in literature neither OXTR nor MOR expressions in the
hippocampus are reported to be high, we also included the CA3
field of this region in our analysis because it appeared intensely
labeled in WT mice. Binding specificity was ensured by com-
parison with the adjacent sections incubated with an excess of
OXT in order to displace any OVTA specifically bound to the
OXTRs.
Autoradiographic 125I microscales (Amersham International,
UK) also were exposed for 72 h and a reference standard curve
was generated. Levels of gray intensity were then converted to
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nanocurie per milligram tissue equivalent by interpolation with
the standard curve.
In order to increase accuracy in identifying the brain regions
within each brain section, the slides labeled for non-specific
binding and the slides labeled for total binding were further col-
ored with Nissl staining and acetylcholinesterase (AChE) staining,
respectively (see below).
HISTOLOGICAL STAINING
Nissl staining
The non-specific binding labeled slides were treated for Nissl stain-
ing. They were defatted by immersion in deionized water (2 min)
followed by subsequent immersions in increasing concentrations
of ethanol (EtOH 70% v/v, 95% v/v, and 100%, 2 min each).
Sections were then rehydrated by 30 s immersions in decreasing
concentrations of ethanol (EtOH 100%, 95% v/v, and 70% v/v)
and after a final dip in deionized water they were left for 6 h in cresyl
violet solution (0.1% cresyl violet, 0.65% sodium acetate trihy-
drate in 0.5% acetic acid, pH 3.3). Differentiation was obtained by
two consecutive changes (3 s each) of deionized water, EtOH 70%
(v/v) and EtOH 95% (v/v), and final dehydration was achieved
by two changes (10 s each) in EtOH 100%. Sections were finally
cleared by immersion in xylene and coverslips were mounted
onto the slides with permanent mounting medium (Entellan®,
Merck-Millipore, Germany) and left to dry overnight under a fume
hood.
Acetylcholinesterase staining
The slides labeled for total binding in autoradiography were
processed for AChE staining following the protocol described by
Franklin and Paxinos (41). All the reagents used in this procedure
were obtained from Sigma Aldrich (Italy) with the exception of the
mounting medium. Sections were immersed over night at room
temperature in an incubation solution (50 mM sodium acetate,
4 mM copper sulfate, 16 mM glycine, 4 mM S-acetylthiocholine
iodide, 10 nM ethopropazine, and pH 5.0 with HCl 1 N) and
developed the following day by incubation for 10 min at room
temperature in a solution containing 1% sodium sulfide (pH 7.5
with glacial acetic acid). The colored precipitate from the reaction
was fixed to the sections by an overnight incubation with formalin
10%. Finally, the slides were left to dry under a fume hood, dehy-
drated by subsequent immersions in ethanol 100% and xylene
100%, coverslipped with permanent mounting medium (Entel-
lan®, Merck-Millipore, Germany) and left to dry overnight under
a fume hood.
For both histological protocols, dried slides were digitalized at
high resolution and the obtained images were used as guidance for
the identification of brain regions within the sections.
BEHAVIORAL EFFECTS OF OXT INTRANASAL ADMINISTRATION
Oxytocin intranasal administration
Adult males were gently handled during the 4 days before testing to
progressively habituate to the intranasal administration protocol.
The first-day they were simply handled, the second-day they were
firmly kept, the third-day they were firmly kept in supine posi-
tion with their back supported by the palm of the manipulator’s
hand, and the fourth-day a drop of saline was introduced in each
nostril. After the last manipulation, they were isolated in clean
cages for 24 h, treated with OXT or saline and their vocalizations
and behavior were recorded.
Oxytocin (Sigma Aldrich, Italy) was dissolved in saline (0.9%
NaCl) to a concentration of 0.6 mg/10 ml. A total volume of 5µl of
the OXT solution was administered intranasally by gently placing
drops in each nostril, that were taken in when the mice reflex-
ively inhaled (600 ng OXT/mouse). The dosage of OXT was based
on data from the literature (34, 38, 39). Control mice received
an equal volume of saline (Veh). A 20-µl Eppendorf pipette
with gel-loading tips was used for administration. Administration
was rapid (<15 s) and handling was consistent across treatment
groups.
Male–female social interaction test
Adult WT and Oprm1−/− males were isolated for 24 h in clean
cages. A total of 17 Oprm1−/− (8 OXT and 9 Veh) and 18 WT
(9 OXT and 9 Veh) males was used as subjects and an equivalent
number of females of the two genotypes were used as partners.
Each animal was used only once and administered with OXT or
saline. The estrous cycle of the female partners was not consid-
ered, as irrelevant on USV quantitative performance during the
first minutes of interaction in sexual naïve males facing unfa-
miliar females (42–44). Five minutes after the male’s intranasal
drug/saline administration, a female of the same genotype was
introduced into the male’s home cage and left for 5 min. The delay
of only 5 min was chosen according to previous studies analyz-
ing the behavioral effects of OXT after intranasal administration
(34, 39). Oprm1−/− males were exposed to Oprm1−/− females
and WT males to WT females. The cage was placed in front of
a video-camera and under a microphone for the recording and
subsequent analysis of behavior and ultrasonic vocalizations. The
videos were analyzed with the Observer software (Noldus Tech-
nology, The Netherlands) and the following males’ behaviors were
considered for the statistical analysis: locomotion, exploration
(sniffing, rearing, digging, and climbing), social investigation (fol-
lowing, sniffing nose, body, and ano-genital region of the partner),
and self-grooming. Ultrasonic vocalizations were recorded using
an UltraSoundGate Condenser Microphone (CM16, Avisoft Bioa-
coustics, Berlin, Germany) lowered 5 cm above the top of the
cage, and analyzed by SasLab Pro (version 4.40; Avisoft Bioa-
coustics). Details concerning USVs recording and analysis can be
found in previous papers (17, 45). According to previous liter-
ature, USVs recorded during the first minutes of male–female
social interaction, are considered to be mainly uttered by the
male (46).
STATISTICAL ANALYSIS
In autoradiography, we quantified the intensity of the binding sig-
nal in Oprm1−/− mice and compared it with the binding showed
by WT mice. Average nanocurie per milligram of tissue equiva-
lents were compared by Student’s t -test with GraphPad Prism 5.0
(GraphPad Software, USA). Results were deemed statistically sig-
nificant when p< 0.05. The effect of the genotype and treatment
on behavioral measures was first analyzed by multiple analysis of
variance (MANOVA) followed by univariate ANOVAs and, in cases
of significance (p< 0.05), Tukey HSD post hoc tests.
Frontiers in Pediatrics | Child and Neurodevelopmental Psychiatry September 2014 | Volume 2 | Article 91 | 4
Gigliucci et al. OXTR up-regulation in Oprm1−/− mice
RESULTS
QUANTITATIVE ANALYSIS OF OXTR DISTRIBUTION IN WT MICE BRAIN
To analyze the pattern of OXTR distribution in Oprm1−/− mice,
we first analyzed [125I]-OVTA binding data in WT mice on which
Oprm1−/− animals are backcrossed. Figure 1 shows representative
autoradiographic sections for the selected area and associated Nissl
staining of adjacent slices; the reported distances from bregma of
the different coronal planes are deduced from a reference mouse
brain atlas (41).
The use of a commercial 125I microscales standard allowed us
to quantify the levels of [125I]-OVTA binding in the brain of our
mice. Quantification of OXTR expression in several areas of the
brain in WT mice is reported in Figure 2. In WT mice, we found
the highest levels of OXTR (here in the text reported as mean
nanocurie per milligram tissue equivalent± SD) in the olfactory
bulb (OB, 0.91± 0.25), the AON (0.88± 0.22), and in some poste-
rior nuclei of the amygdala, specifically the amygdalohippocampal
area (AHiPM, 0.94± 0.16), the posteromedial cortical amygdaloid
area (PMCo, 1.06± 0.16), and the posterior part of the basolateral
amygdaloid nucleus (BLP, 0.87± 0.16). Medium level of OVTA
binding was detected in lateral septum (LS, 0.41± 0.06), the bed
nucleus of the stria terminalis (BNST, 0.34± 0.06), the CA3 field
of the hippocampus (Hipp CA3, 0.30± 0.06), the paraventricular
thalamic nucleus (PV, 0.32± 0.06), and in the medial amygdaloid
nucleus (MeA, 0.26± 0.04). In the other anterior nuclei of the
amygdala analyzed, the CeA nucleus (0.16± 0.05) and the ante-
rior part of the basolateral amygdaloid nucleus (BLA, 0.18± 0.04),
and in the NAcc (0.10± 0.04) OXTR expression was rather low.
Interestingly, Dölen et al. (33) report the basolateral nucleus of
the amygdala as a whole to display “average” OXTR expression,
however, from observation during analysis we noticed a clear dif-
ference in OXTR expression between the anterior and the posterior
parts of this nucleus, therefore, we deemed it more appropriate to
analyze the two subregions separately, distinguishing them into
BLA and BLP. Finally, we found minimal expression of OXTR
in the CPu (0.02± 0.02) and the habenula (Hb, 0.04± 0.02) of
WT mice. Overall, the expression and the distribution of OXTR
in the brains of WT mice, at least in relation to the regions ana-
lyzed, is consistent with what has been previously reported (see
Table 1).
The regions with the lowest OXTR binding signal (CPu and
Hb) presented a 20-fold lower signal compared to the regions
with the highest OXTR expression such as the PMCo. The NAcc
also showed a very low level of OXTR expression, being it around a
tenth of the PMCo’s OXTR expression. All the remaining regions,
such as the anterior nuclei of the amygdala, the LS, the BNST, and
FIGURE 1 | Schematic representation of the brain regions of interest
analyzed in the study. Representative sections of autoradiographic labeling
of OXTR with [125I]-OVTA 20 pM are displayed in grayscale, flanked by
corresponding Nissl stained sections. Red contours outline the regions of
interest analyzed. A sagittal schematic representation of a mouse brain is
reported in the central panel. Lines indicate the antero-posterior localization of
the coronal sections taken into account, defined by the reported distances
(millimeter) from bregma (according to the Franklin and Paxinos (41) mouse
brain atlas). AHiPM, amygdalohippocampal area, posteromedial part; AON,
anterior olfactory nucleus; AONm, anterior olfactory nucleus, medial part;
BLA, basolateral amygdaloid nucleus, anterior part; BLP, basolateral
amygdaloid nucleus, posterior part; BNST, bed nucleus of the stria terminalis;
CeA, central amygdaloid nucleus; CPu, caudate–putamen; Hb, habenular
nucleus; Hipp CA3, hippocampus, field CA3; LS, lateral septum; MeA, medial
amygdaloid nucleus; NAcc, nucleus accumbens; OB, olfactory bulb; PMCo,
posteromedial cortical amygdaloid area.
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the PV, showed instead an average OXTR expression, comprised
between one-fifth and one-half of the PMCo’s levels.
ABSENCE OF MOR INDUCES SPECIFIC INCREASES OF OXTR
EXPRESSION IN THE AONm, IN THE ANTERIOR AMYGDALOID NUCLEI
AND IN NACCS
In order to reveal possible interaction(s) between MOR and OXTR,
we looked for alterations in oxytocinergic binding levels in the
brains of Oprm1−/− mice.
Our data indicate that the expression of OXTR did not dif-
fer significantly between WT and Oprm1−/− mice in the OB
FIGURE 2 | Regional distribution and quantification of OXTR in WT
mice. Average regional expression of OXTR defined by [125I]-OVTA binding
in WT mice. For each animal, final levels of OXTR expression were
calculated averaging data obtained from the different coronal planes
analyzed within the same region of interest. Each bar represents data
expressed as mean and SEM of four animals.
{t -test; [t (4)= 0.139, p= 0.897, n.s.]}, AON {coronal planes
corresponding to its central part; t -test; [t (5)= 0.577, p= 0.589,
n.s.]}, CPu {t -test; [t (4)= 1.238, p= 0.284, n.s.]}, LS {t -test;
[t (5)= 0.046, p= 0.965, n.s.]}, BNST {t -test; [t (5)= 0.315,
p= 0.766, n.s.]}, Hipp CA3 {t -test; [t (5)= 0.160, p= 0.880,
n.s.]}, PV {t -test; [t (5)= 1.269, p= 0.260, n.s.]}, and Hb {t -test;
[t (5)= 0.219, p= 0.835, n.s.]} (Figure 3A). Similarly, the posterior
nuclei of the amygdala (AHiPM, BLP, and PMCo), did not present
alterations in OXTR expression linked to the lack of MOR {t -test;
[t (5)= 1.891, p= 0.117, n.s.], [t (5)= 1.442, p= 0.209, n.s.], and
[t (5)= 1.087, p= 0.327, n.s.], respectively} (Figure 3B).
On the contrary, in the anterior nuclei of the amygdala, and
in particularly in the CeA and MeA, the absence of MOR led
to an up-regulation of OXTR {t -test; [t (5)= 3.102, p< 0.05]
and [t (5)= 4.299, p< 0.01], respectively, Figure 3C}. A trend
(p= 0.07) toward an increase in OXTR was also found in the
anterior basolateral amygdala (Figure 3C).
Another region in which we found an up-regulation of OXTR
is the AONm in the posterior part of AON {t -test; [t (7)= 3.590,
p< 0.01]} (Figure 4A). Because discriminating between the AON
and NAcc is particularly tricky in this area of the brain, we per-
formed AChE staining on the same slices processed for autora-
diography. AChE selectively labels the NAcc and the olfactory
tubercle but not the AON, thus allowing unambiguous identifica-
tion of the two structures. Figures 4C,D show examples of brain
sections labeled with [125I]-OVTA and AChE. In the blow-ups of
the merged images it is evident that the strong autoradiographic
signal observed in this area does not overlap with the AChE stain-
ing, but it is adjacent to it. This allowed us to assign the strong
specific [125I]-OVTA labeling of this region to the AONm. Given
FIGURE 3 | Oprm1−/− mice display increased OXTR expression selectively
in the anterior nuclei of the amygdala. Average regional expression of
OXTR defined by [125I]-OVTA binding in Oprm1−/− mice in comparison with WT
mice. (A) No differences in OXTR expression were detected in Oprm1−/−
mice in several brain regions reported to co-express medium-high levels of
MOR and OXTR. (B) OXTR expression is not influenced by the lack of MOR in
the posterior nuclei of the amygdala whereas (C) an increase of OXTR is
detectable in the anterior nuclei of the amygdala CeA and MeA. Data
expressed as mean and SEM of three to four animals. *p<0.05, **p<0.01
compared to WT controls.
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FIGURE 4 | Oprm1−/− mice display increased OXTR expression in the
medial AON and the nucleus accumbens. Average regional expression of
OXTR defined by [125I]-OVTA binding in Oprm1−/− mice in comparison with WT
mice. OXTR expression is increased in both (A) AONm and (B) NAcc of
Oprm1−/− mice. At the zone of transition between AON and NAcc, distinction
between the two structures was determined by AChE staining, which
selectively labels the NAcc and the olfactory tubercle. (C) The spot of intense
[125I]-OVTA labeling evident in the autoradiographic picture and the AChE
staining, apparently in the same position, do not overlap when the two
images are merged (blow-up), indicating that the NAcc doesn’t express high
levels of OXTR in this area. (D) Superimposition of the autoradiogram and the
AChE staining of a coronal section of the NAcc where the AONm is not
present anymore (blow-up) confirms that this region does not express high
levels of OXTR.
the difficulty, in this region, to discriminate between AONm and
NAcc in absence of AChE staining, we cannot exclude that the area
identified as NAcc in (34) may, instead, correspond to the AONm.
Finally, in the NAcc of Oprm1−/− mice, sampled at three dif-
ferent coronal planes, we found an OXTR level twice as high as
that observed in WT animals {t -test; [t (5)= 2.767, p< 0.05]}
(Figure 4B), suggesting that the NAcc is an anatomical field of
compensative interaction(s) between the oxytocinergic and the
opioidergic systems.
BEHAVIORAL EFFECTS OF INTRANASAL ADMINISTRATION OF
OXYTOCIN IN Oprm1−/− MICE
To evaluate the pro-social effects of OXT, we tested sexu-
ally naive males during courtship, before the initiation of sex-
ual behavior, during the first minutes of interaction with a
female. The behavioral profile of males interacting with females
is shown in Figure 5. The MANOVA indicated no signifi-
cant effect of main factors (genotype: λ= 0.90, F (5/27)= 0.58,
n.s.; treatment: λ= 0.89, F (5/27)= 0.61, n.s.), but a signifi-
cant genotype× treatment interaction (λ= 0.62, F (5/27)= 3.56,
p< 0.05), suggesting that OXT had different effect on mice
behavioral profile according to the genotype. Univariate results
confirmed significant genotype× treatment effect for locomo-
tion [F (1/31)= 5.01, p< 0.05], social investigation [F (1/31)= 4.22,
p< 0.05], and USVs [F (1/31)= 15.29, p< 0.001]. Post hoc analy-
sis showed a significant difference at basal conditions between
Oprm1−/− and WT mice only in ultrasonic vocalizations
(Oprm1−/−+Veh vs. WT+Veh: p< 0.01), and an increase in
the number of USVs due to OXT treatment, selectively in
the Oprm1−/− line (Oprm1−/−+Veh vs. Oprm1−/−+OXT:
p= 0.01). By contrast, OXT did not to significantly modify WT
males’ vocalizations (p= 0.13, n.s.) (Figure 5B). The deficit shown
by Oprm1−/− mice in USVs emission in response to social cues
does not depend on a general impairment in their capacity
to emit high levels of ultrasonic calls or in their sensitivity to
olfactory stimuli, in infancy (16) as well as in adulthood (data
presented here), but suggests lower motivation to interact with
conspecifics.
The low impact of OXT on mutant males’ general social
behavior (Figure 5A) can be related to the role of their mutant
(untreated) females that may prefer to avoid their partner. In this
respect, the USVs test will result more susceptible to treatment, as
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FIGURE 5 | Acute intranasal administration of OXT rescues the
impairments in ultrasound emission in Oprm1−/− mice during
male–female social interaction. Effects of acute intranasal OXT
administration (600 ng) in Oprm1−/− and WT male mice during a 5 min
male–female social interaction. (A) Genotype and OXT treatment do
not affect the amount of time spent in locomotion, exploration,
self-grooming, or social investigation during the test. (B) Oprm1−/−
mice emit a reduced number of ultrasound vocalizations during the
test in comparison with WT mice, and this deficit is completely
rescued by OXT treatment. Data expressed as mean and SEM of
eight to nine animals. *p<0.05, **p<0.01 compared to
Oprm1−/− + veh group.
it only relies on the male behavior, independently on the female
receptivity. Adult male mice emit USVs in the presence of female
conspecifics and these vocalizations, promoting proximity, facili-
tate close social interactions, and sexual behavior. The advantage
of testing males in this context stands in the consistent amount of
ultrasonic calls that characterizes their first approach to the part-
ner, which is independent from female’s receptivity and closely
associated to the male’s motivational state (42–44). As a matter of
fact, males emit USVs also when exposed to female’s cage bedding
or urine (47). When in close proximity, mice can acquire infor-
mation on the partner’s individual characteristics (e.g. sex, rank,
sexual experience, and estrous condition) modulating their social
behavior, and facilitating or avoiding social interactions. Moreover,
the lack of strong deficits during sexual encounters in this mutant
line confirms the entirety of their reproductive capabilities. Finally,
the absence of significant effects of the intranasal OXT treatment
in control male mice is in line with the Huang et al. study, showing
only little changes in social investigation toward a female partner
in C57BL/6J mice (34).
DISCUSSION
The aim of this study was to investigate, in Oprm1−/− mice, the
altered molecular mechanisms underlying the well documented
deficits in social behavior presented by this animal model (16–19).
In particular, we focused on alterations in the expression of brain
OXTRs because they are the target of intranasally administered
OXT, a promising new treatment for social deficits in autism (35,
48, 49). Our data show an OXTR up-regulation in specific brain
regions of MOR-null mice, such as AONm, CeA, MeA, and NAcc.
All these regions are involved in the regulation of social behav-
ior, but, in our study, not all regions involved in social behavior
that express OXTR were found to up-regulate the receptor. Fur-
thermore, no correspondence between a high expression level of
the OXTR and its up-regulation was observed. In particular: (1)
regions that display very high levels of OXTR such as LS and BNST
did not show any OXTR up-regulation and (2) of the regions
where we observed OXTR up-regulation, three (AON, MeA, and
CeA) have a high level of OXTR expression, and one (NAcc) has
a medium-low level. Interestingly, a region-selective OXTR up-
regulation was also observed in a recent paper in which OXTR
expression levels were analyzed in the mouse brain after mor-
phine treatment and withdrawal (50). However, the regions found
in the aforementioned pharmacological manipulation study did
not overlap with those described in the present study, an obser-
vation consistent with multiple patterns of receptor modulation
linked to specific genetic, developmental, and pharmacological
conditions. AONm, MeA, CeA, and NAcc are, nevertheless, all
characterized by a medium-high MOR expression in WT mice
(Table 1), suggesting a local interplay between the two recep-
tor systems, which may involve neuroanatomical, cellular, or even
subcellular interactions.
An open question regards, which is the neurobiological mech-
anism at the basis of the OXTR up-regulation. It is difficult to
answer to this question as the OXT content and capability of OXT
release in the hypothalamus of Oprm1−/− mice has not been eval-
uated so far. If reduced, an up-regulation of the OXTR in target
sites of the neuropeptide’s action may represent a compensatory
mechanism to normalize the neuronal responses to reduced levels
of secreted OXT. Becker et al. (19) actually found a reduced level
of OXT transcript in Oprm1−/− mice, but this impairment was
restricted to the NAcc, leaving the overall levels of OXT undeter-
mined. A second possibility implies direct molecular interactions
between OXTR and MOR. G-protein coupled receptors such as
OXTR and MOR, can form homo- (with another molecule of
the same receptor) or hetero- (with receptors from other fami-
lies) dimers and it has been shown that this physical association
can modulate receptor binding and function (51). Interestingly,
in mice lacking the alpha2A-adrenergic receptor, morphine has a
reduced analgesic effect, suggesting that alterations in the nora-
drenergic system induce alterations in the opioid system (52).
Molecular dimerization of MOR and alpha2A-adrenergic receptor
has been demonstrated in both cell lines and primary neuronal
cultures (53) and it has been shown that, in MOR–alpha2A-
adrenergic receptor dimers, the activation of MOR by morphine
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inhibits the adjacent alpha2A-receptor by blocking its ability to
activate the G-proteins even in the presence of noradrenaline (54).
If dimeric interactions occur between MOR and OXTR, the lack
of MOR may result in specific alterations of OXTR pharmacology
in the brain regions in which the two receptors physically inter-
act. Even if only speculative at present, this hypothesis will deserve
further investigation.
A second question is: what are the neuroanatomical basis of the
specific OXTR up-regulation in NAcc, CeA, MeA, and AONm of
MOR-null mice?
As the NAcc is involved in the processing of social motivation
and reward, it is not surprising that alterations in OXTR levels
in NAcc have been found to be linked to altered social behaviors.
First of all, natural variability in OXTR expression in the NAcc
has been associated to social organization and mating behavior in
voles, being the level of OXTR in the NAcc higher in monogamous
voles displaying greater maternal care (55). Many other studies
associated OXTR density in the NAcc to the degree of maternal
and affiliative behavior and partner preference formation (56–
60). Regardless of whether differences in OXTR expression are
intrinsic (due to individual or species-related variability) (55, 57,
58), exogenously induced by viral-mediated over expression (35,
59, 60), or physiologically caused by labor and lactation (56), an
higher OXTR level in these brain regions correlates with more
pronounced social behavior. On the contrary, reduced levels of
OXTR binding in the NAcc were observed in voles after pater-
nal deprivation (61). At the neurophysiological level, presynaptic
OXTRs have been recently shown to be required for social reward
in the NAcc (33). In particular, OXTRs located on axonal terminals
of serotoninergic projections coming from the dorsal raphe have
been found to elicit Long-Term Depression (LTD) in medium
spiny neurons by activation of serotoninergic 5HT1B receptors
(33). NAcc neurons express high levels or MOR, but the neuronal
populations that mediate all the distinct opiate effects remain elu-
sive; recently, a subpopulation of striatal direct-pathway neurons
was shown to support opiate reward-driven behaviors (62), and
specific “hotspots” involved in the modulation of hedonic “liking”
responses in which opioid receptors might function as hedonic
enhancers have been identified (63). Furthermore, activation of
MORs within the dorsal striatum appears to be critical to partner
preference formation by generating socially motivated behavioral
responses (9). OXTR may thus be postulated to act on specific
MOR positive NAcc subpopulation(s) to regulate specific aspects
or components of social reward, possibly via a presynaptic mecha-
nism similar to that observed for the OXT induced LTP at 5HT1B
receptors.
The different nuclei of the amygdala are responsible for the
processing of emotional content of both positive and negative
experiences. The CeA, as part of the brain’s reward circuitry,
is important in processing positive emotions and, particularly,
in the learning process of stimulus–reward association (64, 65).
Moreover, the CeA is strongly implicated in the expression of
fear. In mice, a neural circuit within the CeA that gates fear
responses activating active strategies of risk assessment or pas-
sive expression of fear (freezing) has been described and, in this
circuit, the OXTR was found to be a key player (66). Interest-
ingly, as it has been observed that excessively aggressive animals
show highest OXTR binding in the CeA (67), it is tempting
to speculate that the increased aggressive behavior observed in
Oprm1−/− mice (19) may be linked to the selective up-regulation
of OXTR in the CeA. The MeA is highly activated during social
encounters and recognition, thus representing a critical neu-
roanatomical substrate of social cognition. The recognition of
conspecifics is an initial and crucial condition for the establish-
ment of social and sexual behavior. Odor, scent, and pheromones
mediate sexual and competitive interactions, and are important in
individual and kin recognition and mate selection. In rodents,
odor signals are processed by two systems: the main olfactory
pathways and the vomeronasal pathway, both directly and indi-
rectly projecting to the MeA, a key region for the processing of
chemosensory information (68). OXT-deficient mice are not able
to recognize a previously encountered, familiar conspecific, and
this social recognition behavior can be restored with a direct
microinjection of OXT into the MeA of OXT KO mice, indi-
cating that OXT in the MeA is both necessary and sufficient for
social recognition (69, 70). Furthermore, male social interest cor-
related positively with OXTR in the MeA, while female social
interest correlated negatively with OXTR expression in the same
region (71). Finally, it has recently been shown that OXT-mediated
LTD in the AOB–MeA pathway is directly involved in long-term
social recognition memory formation (72). The up-regulation of
OXTR in MeA may thus be involved in the pharmacological res-
cue of intranasal OXT on the social interaction test used in our
study.
The up-regulation of OXTR in AONm of Oprm1−/− remains of
difficult interpretation. The pars medialis of the AON can be dis-
tinguished from the rest of the AON by cytoarchitectural features
and projection patterns (73, 74), suggesting a different role than
a station along the main olfactory and the vomeronasal pathways,
but the role of OXTR in this region is still undefined.
Finally, what is the pathophysiological meaning of the OXTR
up-regulation in Oprm1−/− mice? As Oprm1−/− mice do have
severe defects in social interaction and social memory (19), the up-
regulation of OXTR binding sites observed in Oprm1−/− mice is
apparently unable to normalize social cognition in these animals.
Nevertheless, the up-regulation of OXTR may contribute to the
rescue effects observed with intranasal OXT in MOR-null animals,
as these KO animals completely recovered from communication
deficits during the first minutes of social interaction, not differing
from wild type animals anymore. Indeed, the present study con-
firms the efficacy of OXT treatment in reverting social deficits in
a mouse model in which the oxytocinergic system underwent a
compensatory modulation. These findings are of high relevance
in the autism field as they further validate the use of OXT in ASD
regardless of the primary etiopathogenetic cause(s) but solely on
the basis of the social endophenotype. To fully understand the role
of OXTR compensatory roles, it will be very interesting to inves-
tigate in detail the time-course of OXTR up-regulation in crucial
periods of prenatal and post-natal life, including birth, weaning,
and sexual maturity. Similarly, we only investigated male animals,
but, due to the sexual dimorphism of OXTR expression in different
species and brain areas (75, 76), similar analysis in female animals
is warranted, as this may have a profound impact on the design of
therapeutic schemes and doses.
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In conclusion, the OXT system may act as a downstream effector
toward social behaviors, compensating and/or bypassing genetic
alterations in upstream circuits that produce social deficits. Such
a hypothesis would justify the use of this neuropeptide in a wide
variety of human conditions characterized by defects in social
cognition and/or reward, such as ASDs, upon demonstration of
OXT/OXTR modification(s) in the brain of affected individu-
als. Moreover, the results presented here further corroborate the
hypothesis that alterations in the OXTergic system are involved in
the pathophysiology of autism and that administration of OXT to
such altered system might restore a balance in the neural circuitries
involved in social behavior.
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